tiprankstipranks
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
US Market

Galmed Pharmaceuticals (GLMD) Financial Statements

Compare
1,260 Followers

Galmed Pharmaceuticals Financial Overview

Galmed Pharmaceuticals's market cap is currently $4.23M. The company's EPS TTM is $-12.037; its P/E ratio is ―; Galmed Pharmaceuticals is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -31.00K$ -35.00K$ -42.00K$ -39.00K$ -35.00K
Operating Income$ 7.49M$ -17.65M$ -32.88M$ -30.21M$ -22.38M
EBITDA$ -6.87M$ -17.62M$ -32.84M$ -30.17M$ -22.34M
Net Income$ -6.91M$ -18.57M$ -31.95M$ -27.61M$ -18.54M
Balance Sheet
Cash & Short-Term Investments$ 12.64M$ 13.79M$ 34.81M$ 50.89M$ 75.49M
Total Assets$ 16.63M$ 16.56M$ 36.60M$ 52.38M$ 77.14M
Total Debt$ 41.00K$ 44.00K$ 229.00K$ 216.00K$ 352.00K
Net Debt$ -2.82M$ -1.97M$ -2.65M$ -6.73M$ -15.58M
Total Liabilities$ 2.75M$ 3.14M$ 6.11M$ 8.23M$ 7.29M
Stockholders' Equity$ 13.88M$ 13.42M$ 30.50M$ 44.15M$ 69.85M
Cash Flow
Free Cash Flow$ -6.14M$ -18.50M$ -32.90M$ -26.33M$ -14.95M
Operating Cash Flow$ -6.14M$ -18.50M$ -32.89M$ -26.29M$ -14.94M
Investing Cash Flow$ 800.00K$ 17.56M$ 11.46M$ 16.54M$ 6.68M
Financing Cash Flow$ 6.18M$ 70.00K$ 17.37M$ 768.00K$ 143.00K
Currency in USD

Galmed Pharmaceuticals Earnings and Revenue History

Galmed Pharmaceuticals Debt to Assets

Galmed Pharmaceuticals Cash Flow

Galmed Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis